News & Articles
25
Selected Filters:
Industry News
Nobelpharma signs a license agreement for ProBioGen’s vaccine manufacturing platform AGE1.CR.pIX
Nobelpharma will use ProBioGen’s cell-based production platform AGE1.CR.pIX to develop their lead vaccine
Industry News
ProBioGen signs agreement for manufacturing process development of vaccine project
Earlier work has already confirmed the versatility and benefit of ProBioGen’s vaccine development platform
Industry News
ProBioGen licenses GlymaxX technology to AbbVie
Industry News
ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics
Afucosylation can enable more precise assessment of allergic sensitization
